Helping immunotherapy realize its full potential to treat cancer - through the gut microbiome.

MISSION
To develop therapies that modulate the gut microbiome to improve the outcomes and quality of life of patients with cancer.

Sidekick Bio is a biopharmaceutical company developing innovative therapies that alter the gut microbiome in order to improve the safety and efficacy of cancer immunotherapy and enable more patients to achieve a durable response. Sidekick Bio is committed to advancing the field of microbiome-based medicine and improving outcomes for patients with cancer.


FOUNDING TEAM
Sidekick Bio was founded by a team of experienced biopharma executives with deep expertise in the microbiome, oncology, and clinical development, passionate about advancing our science into transformative medicines.